Utah’s recent reforms help clarify this shift. Beginning July 1, 2026, the state will impose a new tax of 11 cents per cigarette, along with a new framework to govern nicotine pouches: $1 per can, with additional charges as the pouch count increases. This replaces older weight-based systems with a hybrid unit-and-volume tax. And updated definitions ensure that all nicotine products, including pouches and e-cigarettes, are explicitly covered in the tax code. On paper, this is modernization. In practice, it indicates a wider alignment: the fundamental products as if they present similar risks.
Taxing safer alternatives like cigarettes
Why does this matter? Because nicotine pouches are not cigarettes. They don’t have tobacco leaf, don’t burn, and create no smoke. There is an increasing body of evidence to suggest they are far less harmful than smoking cigarettes and can have a meaningful role in cessation.” Research on contemporary oral nicotine products suggests they may assist smokers in transitioning away from combustible tobacco — especially in conjunction with behavioral support. Real-world data from Nordic countries provide additional support for this consideration; in these countries, the wide adoption of oral nicotine has been associated with dramatic buildups in smoking prevalence.
In Washington State, for example, a 95% excise tax has already gone into effect — nearly doubling the retail price of many nicotine products. Similar actions in Minnesota and Rhode Island highlight an unmistakable trend: With cigarette use falling, governments are widening their tax base to add new categories of nicotine. Just in 2025, dozens of legislative proposals sought to rein in nicotine pouches, a strong sign that the tide was turning against favorable treatment for all brands.
What are the repercussions?
Economic modeling and real-world evidence both suggest that excessive taxation of reduced-risk products may delay smoking cessation — or even reverse it.
But this method comes with a cost. Economic modeling and real-world evidence both suggest that excessive taxation of reduced-risk products may delay smoking cessation — or even reverse it. If the price gap between cigarettes and competitors narrows, so does the incentive to switch. Cost is still one of the most potent motivators for adult smokers seeking lower-risk alternatives.
In Thailand, officials have adopted a far different — but equally aggressive — tack. Instead of taxation, enforcement has served as the main tool. The government has stepped up enforcement against sales and marketing of nicotine pouches, especially in tourist areas and on online marketplaces. These include fines and possible jail time, reflecting widespread concerns about youth use and unregulated sales. If couched as a public health intervention, such stringent enforcement could drive consumers into underground markets, where product quality and safety are far less assured.
Time to stop ignoring science and real-world evidence
This makes the current wave of U.S. tax hikes look increasingly out of step with global evidence. Nowhere is the contrast clearer than in Sweden, which just reached its lowest-ever smoking rates. Among adults, daily smoking prevalence has fallen to just 3.7%, fueled in large part by the widespread availability of oral nicotine products like snus, as well as nicotine pouches. Instead of demonizing these substitutes, Sweden has incorporated them into a harm-reduction paradigm — outcomes over ideology (but more on that in our next article.)
Given all this, taxing nicotine pouches the same way as cigarettes seems less like good policy and more like using a blunt tool. While it’s important to address youth access and product standards, these issues can be addressed through targeted regulations rather than broad taxes that may have unintended consequences.
